Cardiac Transplantation and Surgery for Heart Failure Post–Heart Transplant Survival Is Inferior at Low-Volume Centers Across All Risk Strata
نویسندگان
چکیده
Background—Previous studies have demonstrated a relationship between increasing center volume and cardiac transplant outcomes. The purpose of this study was to confirm a relationship between post–heart transplant outcomes and center experience and to determine whether this relationship persists among lowand high-risk heart transplant recipient–donor pairs. Methods and Results—The United Network for Organ Sharing (UNOS) provided deidentified patient-level data. Analysis included 8029 heart transplant recipients aged 18 years and transplanted between January 1, 2001 and December 31, 2006 with follow-up available through February 3, 2009. The primary outcome was observed 1-year posttransplant graft survival. Multivariable logistic regression was used to calculate expected 1-year survival for recipients. Threshold analysis identified 3 discrete risk groups of transplant recipients: high-risk, moderate-risk, and low-risk. Three discrete risk strata for center volume: low ( 10.5 recipients/yr), intermediate (10.5 to 47 recipients/yr), and high ( 47 recipients/yr) were also identified. 2 test was used to compare 1-year survival at lowand intermediatewith high-volume centers. In multivariable logistic regression analysis, annual center volume was significantly associated with posttransplant graft survival at 1 year (odds ratio [OR] 0.995, 0.992 to 0.999; P 0.010) and primary graft failure (OR 0.985, 0.972 to 0.997; P 0.015), but not stroke (OR 0.996, 0.990 to 1.003; P 0.295), infection (OR 1.001, 0.998 to 1.003; P 0.613), or dialysis (OR 1.001, 0.997 to 1.005; P 0.522). Log-rank test demonstrated significant difference in survival between volume groups with respect to high-risk (P 0.0032) and low-risk (P 0.00415), but not moderate-risk (P 0.128) patients. Conclusions—A direct relationship existed between increasing center volume and improved graft survival. Across all recipient–donor pair risk strata, posttransplant graft survival at 1 year was significantly lower at low-volume centers. The volume–outcomes relationship was strongest in the highest-risk recipient–donor category. (Circulation. 2010;122[suppl 1]:S85–S91.)
منابع مشابه
Post-heart transplant survival is inferior at low-volume centers across all risk strata.
BACKGROUND Previous studies have demonstrated a relationship between increasing center volume and cardiac transplant outcomes. The purpose of this study was to confirm a relationship between post-heart transplant outcomes and center experience and to determine whether this relationship persists among low- and high-risk heart transplant recipient-donor pairs. METHODS AND RESULTS The United Net...
متن کاملHeart Transplantation in Biventricular Congenital Heart Disease: Indications, Techniques, and Outcomes
Heart transplantation is an accepted therapeutic modality for end-stage congenital heart disease for both biventricular and univentricular anomalies. Many transplant centers have pushed the limits of transplantation to include patients with high pulmonary vascular resistance, high panel reactive antibodies, positive cross-matches, and ABO-incompatibility. Excellent results have been possible, p...
متن کاملOsteoporosis after stem cell transplantation
Background Stem cell transplantation has become as a novel treatment for end-stage kidney, lung, heart , liver diseases and several hematologic disorders. Improved survival of transplant recipients has raised awareness of post-transplant complications. One of these complications is transplant-related osteoporosis. Methods In this manuscript we review prevention methods for transplant-relat...
متن کاملCardiac retransplantation is an efficacious therapy for primary cardiac allograft failure
BACKGROUND Although orthotopic heart transplantation has been an effective treatment for end-stage heart failure, the incidence of allograft failure has increased, necessitating treatment options. Cardiac retransplantation remains the only viable long-term solution for end-stage cardiac allograft failure. Given the limited number of available donor hearts, the long term results of this treatmen...
متن کاملFive-Year Experience of Liver Transplant at Kerman University of Medical Sciences: Afzalipoor Hospital
Introduction: The only option for treatment of end stage liver diseases is liver transplantation. Afzalipour Hospital in Kerman, Iran is the third largest liver transplantation center in Iran. In this study, the outcomes of this center have been studied during the past 5 years. Methods: In this cross-sectional study, the pre and post transplantation’s clinical, demographic and outcome data of ...
متن کامل